Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Pallini

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Journal of Neurosurgery|April 15, 2003
Chordoma of the skull base: predictors of tumor recurrenceRoberto Pallini, Giulio Maira, Francesco Pierconti, et al.
International Journal of Molecular Sciences|July 29, 2023
Neuromodulation for Brain Tumors: Myth or Reality? A Narrative ReviewQuintino Giorgio D'Alessandris, Grazia Menna, Alessandro Izzo, et al.
Purinergic Signalling|May 16, 2015
Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cellsIolanda D'Alimonte, Eleonora Nargi, Mariachiara Zuccarini, et al.
Frontiers in Oncology|March 15, 2021
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation <i>In Vitro</i>Silvia Matteoni, Paola Matarrese, Barbara Ascione, et al.
Acta Neurochirurgica|November 8, 2012
Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experienceQuintino Giorgio D'Alessandris, Nicola Montano, Tonia Cenci, et al.
Pharmaceutics|October 27, 2022
Development and Validation of a HPLC-MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing MiceTommaso Ceruti, Quintino Giorgio D'Alessandris, Roberta Frapolli, et al.
International Journal of Cancer|December 7, 2005
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenograftsRoberto Pallini, Antonio Sorrentino, Francesco Pierconti, et al.
Cancer|November 8, 2012
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesisMaurizio Martini, Tonia Cenci, Giorgio Quintino D'Alessandris, et al.
The Lancet. Neurology|November 20, 2022
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trialSilvia Lanfranconi, Elisa Scola, Jennifer M T A Meessen, et al.
International Journal of Molecular Sciences|January 21, 2023
Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like CellsValentina Dini, Giuseppe Esposito, Andrea Sacconi, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Journal of Neurosurgery|April 15, 2003
Chordoma of the skull base: predictors of tumor recurrenceRoberto Pallini, Giulio Maira, Francesco Pierconti, et al.
International Journal of Molecular Sciences|July 29, 2023
Neuromodulation for Brain Tumors: Myth or Reality? A Narrative ReviewQuintino Giorgio D'Alessandris, Grazia Menna, Alessandro Izzo, et al.
Purinergic Signalling|May 16, 2015
Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cellsIolanda D'Alimonte, Eleonora Nargi, Mariachiara Zuccarini, et al.
Frontiers in Oncology|March 15, 2021
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation <i>In Vitro</i>Silvia Matteoni, Paola Matarrese, Barbara Ascione, et al.
Acta Neurochirurgica|November 8, 2012
Targeted therapy with bevacizumab and erlotinib tailored to the molecular profile of patients with recurrent glioblastoma. Preliminary experienceQuintino Giorgio D'Alessandris, Nicola Montano, Tonia Cenci, et al.
Pharmaceutics|October 27, 2022
Development and Validation of a HPLC-MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing MiceTommaso Ceruti, Quintino Giorgio D'Alessandris, Roberta Frapolli, et al.
International Journal of Cancer|December 7, 2005
Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenograftsRoberto Pallini, Antonio Sorrentino, Francesco Pierconti, et al.
Cancer|November 8, 2012
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesisMaurizio Martini, Tonia Cenci, Giorgio Quintino D'Alessandris, et al.
The Lancet. Neurology|November 20, 2022
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trialSilvia Lanfranconi, Elisa Scola, Jennifer M T A Meessen, et al.
International Journal of Molecular Sciences|January 21, 2023
Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like CellsValentina Dini, Giuseppe Esposito, Andrea Sacconi, et al.
Pageof 16